StemSynergy Therapeutics®
"Innovative Stem Cell Research. Targeted Cancer Therapeutics."

Scientific Team

The SSTI team has extensive working experience in the biotech/pharmaceutical industry.  Our team has broad experience in medicinal chemistry, drug development and cancer biology to progress our programs into the clinical stages and beyond.

Dennis Fei, Ph.D.

Dr. Dennis Fei is a Senior Principal Scientist at SSTI. His research focused on elucidating the functions of novel oncogenes and how developmental pathways contribute to cancer. Dr. Fei received his Ph.D. degree in Pharmacology and Toxicology at Dartmouth College, and completed his postdoctoral training at National Human Genome Research Institute and Weill Cornell Medicine.

Scientific Team

SSTI has a multidisciplinary team of scientists.

Meet the Team


Meet the founders behind StemSynergy Therapeutics, Inc.



SSTI targets cancer stem cell pathways that drive tumor growth.

Scientific Programs